Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FENWM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,481
Award facts
- Contract value 100% obligated
- $7,481.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $7,481.25 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, awarded on October 21, 2025, with an ultimate completion date of October 22, 2025, represents a component of DMS Pharmaceutical Group's broader engagement as a regional prime vendor under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The delivery order was issued without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. No subcontractors were identified in the award documentation.
DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract under the PPV-G GEN V program with a $499,999,999 ceiling value extending through December 31, 2036, which positions the company as a critical pharmaceutical supplier for Department of Defense healthcare operations globally. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to enable the Defense Logistics Agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables to support recurring medical supply needs of military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance on numerous delivery orders demonstrates its capability to fulfill the diverse and specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DU26FENWM?
SPE2DU26FENWM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 21, 2025.
How much is contract SPE2DU26FENWM worth?
The government has obligated $7,481 on SPE2DU26FENWM.
Is contract SPE2DU26FENWM an order under another contract?
Yes. SPE2DU26FENWM is a delivery order under SPE2DU25D9418, an indefinite delivery contract.
Was contract SPE2DU26FENWM competed?
The extent of competition for SPE2DU26FENWM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award